Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoking Cessation 1 Motor Activity 1 Lung Neoplasms 1 Inflammation 1

Interventions

Cyclophosphamide 2067 Radiotherapy 1990 Cisplatin 1856 Carboplatin 1560 Gemcitabine 1454 Paclitaxel 1320 Bevacizumab 1320 pembrolizumab 1238 Docetaxel 1227 Oxaliplatin 1184 Capecitabine 1178 Fluorouracil 1083 Dexamethasone 979 Magnetic Resonance Spectroscopy 971 Nivolumab 936 Rituximab 929 Drug Therapy 915 Surveys and Questionnaires 899 Doxorubicin 845 Etoposide 843 Radiosurgery 816 Blood Specimen Collection 816 Irinotecan 784 Cytarabine 743 fludarabine 726 Leucovorin 684 Surgical Procedures, Operative 640 Lenalidomide 618 Biopsy 594 fludarabine phosphate 569

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × cytisine × Clear all

NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡